BioCentury
ARTICLE | Company News

Cumencor Pharmaceuticals Inc., MicuRx, Pfizer deal

April 12, 2010 7:00 AM UTC

MicuRx and Cumencor partnered with Pfizer to discover and develop antibiotics to treat multi-drug resistant tuberculosis (MDR-TB) using MicuRx's combinatorial and medicinal chemistry technology. MicuR...